India to Brazil: Nivolumab Export Trade Route

The India to Brazil Nivolumab corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $280.5K USD. The route is dominated by CORSANTRUM TECHNOLOGY, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $4.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with nivolumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 27.1%, placing it at rank #7 among India's top nivolumab export destinations globally.

On the import side, key buyers of Indian nivolumab in Brazil include AS PER INVOICE, TO THE ORDER, JAIR CARLOS DE ARAUJO and 13 others. AS PER INVOICE is the single largest importer with 7 shipments valued at $72.9K USD.

India's nivolumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. CORSANTRUM TECHNOLOGY with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CORSANTRUM TECHNOLOGY, VAMA LIFECARE PRIVATE LIMITED, SPECIALITY MEDICINES LIMITED — together account for 77% of total trade value on this route. The average shipment value of $4.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as brand name: opdivo 100mg injection eachtablet contains nivolumab (100mg) and harmless pharmaceutical medicines for human use nivolumab 100 mg injection, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AS PER INVOICE is the largest importer with 7 shipments worth $72.9K USD — representing 26% of all nivolumab imports from India on this route. A total of 16 buyers are active on this corridor.